脂質ナノ粒子の世界市場レポート 2024年

脂質ナノ粒子の市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR17.0％で19億4,000万米ドルに成長します。予測期間中に予想される成長は、いくつかの主要な促進要因に起因しています。これらには、慢性疾患の有病率の上昇、RNAベースの治療薬に対する需要の高まり、先進的な遺伝子導入システムへの関心の高まり、個別化医療への注目の拡大、研究開発イニシアティブへの投資の増加などが含まれます。これらの要因が脂質ナノ粒子市場の成長を促進し、イノベーションと新たな治療ソリューションの開発を促進すると予想されます。予測期間中に予想される主な動向には、ドラッグデリバリー技術の進歩、革新的なドラッグデリバリーシステムの出現、LNP開発プロセスにおける人工知能の統合などが含まれます。これらの動向は、脂質ナノ粒子をベースとした治療の効率と効果を高め、市場の成長をさらに促進し、治療の可能性を拡大するものと考えられます。

慢性疾患の有病率の高まりは、脂質ナノ粒子市場の成長の起爆剤となっています。慢性疾患は、3カ月以上続く持続的な状態を特徴とし、糖尿病、高血圧、その他さまざまな健康障害を含みます。慢性疾患の罹患率上昇の要因としては、健康行動の低下、高齢化、ライフスタイルの選択、タバコの使用、栄養不足、運動不足、過度のアルコール摂取などが挙げられます。脂質ナノ粒子は、mRNA治療薬やワクチンの有効性を高めることにより、慢性疾患管理における有望な手段を提示します。情勢は、様々な慢性疾患の治療状況に革命をもたらし、より効果的な管理戦略や患者の転帰を改善する可能性を提供しています。例えば、国際糖尿病連合が2021年に発表したデータによると、20歳から79歳の成人のうち5億3,700万人が糖尿病患者であり、2030年には6億4,300万人、2045年には7億8,300万人に増加すると予測されています。

市場競争の主役は、競争優位性を獲得するために、サーキュラーRNA（circRNA）と脂質ナノ粒子（LNP）製剤の技術革新を先導しています。サーキュラーRNA（circRNA）と脂質ナノ粒子（LNP）製剤の進歩は、共有結合で閉じたループ構造を特徴とする一本鎖RNAであるcircRNAを含むRNAフォーマットのレパートリーを拡大します。例えば、米国を拠点とする著名なライフサイエンス企業であるGenScript Biotechは、2023年9月に試薬サービスを増強し、サーキュラーRNA（circRNA）と脂質ナノ粒子（LNP）製剤を包含するようになりました。これらの強化されたサービスは、タンパク質代替療法、遺伝子・細胞治療ソリューションの提供というGenScriptのコミットメントに沿ったものであり、同社の受託製造試薬サービスの一環としてすぐに利用できます。CircRNAは、従来の線状RNAに比べ、安定性が高く、分解が遅く、低用量で治療用タンパク質レベルを達成できる可能性があるなど、いくつかの利点があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の脂質ナノ粒子市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の脂質ナノ粒子市場の実績：規模と成長、2018～2023年
• 世界の脂質ナノ粒子市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の脂質ナノ粒子市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
• ナノ構造脂質キャリア（NLC）
• 固体脂質ナノ粒子（SLN）
• その他のタイプ
• 世界の脂質ナノ粒子市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
• 研究
• 治療薬
• 世界の脂質ナノ粒子市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
• 製薬・バイオテクノロジー企業
• 学術・研究センター
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界の脂質ナノ粒子市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の脂質ナノ粒子市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脂質ナノ粒子市場：競合情勢
• 脂質ナノ粒子市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Bayer AG
  • Abbott Laboratories

第31章 その他の大手企業と革新的企業

• Amgen Inc
• The Merck Group
• Evonik Industries AG
• BioNTech SE
• Moderna Inc.
• Sanofi SA
• Solid Biosciences Inc.
• AstraZeneca PLC
• NOF Corporation
• Alnylam Pharmaceuticals Inc.
• Nanomerics Ltd.
• CordenPharma International
• Nippon Fine Chemical
• Helix Biotech Inc.
• Dicerna Pharmaceuticals

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的分析

第36章 付録

Lipid nanoparticles are a class of nanoparticles primarily composed of lipids, essential fatty substances integral to cell membranes. These nanoparticles typically consist of a lipid bilayer or solid lipid matrix, characterized by their small size, typically ranging from 10 to 1000 nanometers in diameter.

The primary types of lipid nanoparticles include nanostructured lipid carriers (NLCs), solid lipid nanoparticles (SLNs), and other variations. Nanostructured lipid carriers (NLCs) are small structures composed of fats capable of encapsulating drugs or nutrients. They find applications in various fields including research and therapeutics and are utilized by diverse end-users such as pharmaceutical and biotechnology companies, academic and research institutions, and others.

The lipid nanoparticles market research report is one of a series of new reports from The Business Research Company that provides lipid nanoparticles market statistics, including lipid nanoparticles industry global market size, regional shares, competitors with a lipid nanoparticles market share, detailed lipid nanoparticles market segments, market trends, and opportunities, and any further data you may need to thrive in the lipid nanoparticles industry. This lipid nanoparticles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lipid nanoparticles market size has grown rapidly in recent years. It will grow from $0.89 billion in 2023 to $1.04 billion in 2024 at a compound annual growth rate (CAGR) of 16.9%. The growth observed in the historic period can be attributed to several key factors. These include the heightened focus on the development of LNP-based drugs, significant investments in research infrastructure, and the steady increase in healthcare expenditures. These factors collectively contributed to the expansion of the lipid nanoparticle market, driving innovation and advancements in drug delivery technologies.

The lipid nanoparticles market size is expected to see rapid growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 17.0%. The anticipated growth in the forecast period can be attributed to several key drivers. These include the rising prevalence of chronic diseases, a growing demand for RNA-based therapeutics, increasing interest in advanced gene delivery systems, the expanding focus on personalized medicine, and rising investments in research and development initiatives. These factors are expected to fuel the growth of the lipid nanoparticle market, driving innovation and the development of new therapeutic solutions. Key trends expected in the forecast period encompass advancements in drug delivery technologies, the emergence of innovative drug delivery systems, and the integration of artificial intelligence in LNP development processes. These trends are poised to enhance the efficiency and effectiveness of lipid nanoparticle-based therapies, further propelling market growth and expanding therapeutic possibilities.

The escalating prevalence of chronic diseases is serving as a catalyst for the growth of the lipid nanoparticles market. Chronic diseases, characterized by enduring conditions lasting over three months, encompass ailments like diabetes, hypertension, and various other health disorders. Contributing factors to the rising rates of chronic diseases include poor health behaviors, an aging population, lifestyle choices, tobacco use, inadequate nutrition, physical inactivity, and excessive alcohol consumption. Lipid nanoparticles present a promising avenue in chronic disease management by enhancing the efficacy of mRNA therapeutics and vaccines. LNPs revolutionize the treatment landscape for a spectrum of chronic diseases, offering prospects for more effective management strategies and potentially improved patient outcomes. For instance, data published by the International Diabetes Federation in 2021 revealed that 537 million adults aged 20 to 79 were living with diabetes, with projections indicating an increase to 643 million by 2030 and 783 million by 2045, underscoring the pivotal role of LNPs in addressing the rising burden of chronic diseases.

Key players in the lipid nanoparticles market are spearheading innovations in circular RNA (circRNA) and lipid nanoparticle (LNP) formulations to gain a competitive advantage. The advancement of circular RNA (circRNA) and lipid nanoparticle (LNP) formulations expands the repertoire of RNA formats, including circRNA, a single-stranded RNA characterized by a covalently closed loop structure. For instance, in September 2023, GenScript Biotech, a prominent US-based life sciences company, augmented its reagent services to encompass circular RNA (circRNA) and lipid nanoparticles (LNP) formulation. These enhanced services align with GenScript's commitment to providing protein replacement therapies, gene and cell therapy solutions, and are readily available as part of the company's contract-manufactured reagent services. CircRNA offers several advantages over traditional linear RNA, including heightened stability, slower degradation, and the potential to achieve therapeutic protein levels at lower dosages.

In February 2022, Merck & Co., Inc., a leading US-based pharmaceutical company, completed the acquisition of Exelead for $780 million in cash. This strategic acquisition bolsters Merck's Life Science division by enabling the provision of comprehensive contract development and manufacturing organization (CDMO) services across the mRNA value chain. Exelead, a reputable US-based biopharmaceutical CDMO, specializes in the production of PEGylated products and complex injectable formulations, including lipid nanoparticle (LNP) based drug delivery technology, augmenting Merck's capabilities in advancing innovative therapies for chronic diseases.

Major companies operating in the lipid nanoparticles market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Abbott Laboratories, Amgen Inc, The Merck Group, Evonik Industries AG, BioNTech SE, Moderna Inc., Sanofi SA, Solid Biosciences Inc., AstraZeneca PLC, NOF Corporation, Alnylam Pharmaceuticals Inc., Nanomerics Ltd., CordenPharma International, Nippon Fine Chemical, Helix Biotech Inc., Dicerna Pharmaceuticals, Gattefosse SAS, Arbutus Biopharma, Avanti Polar Lipids, IOI Oleo GmbH, Evox Therapeutics Ltd.

North America was the largest region in the lipid nanoparticles market in 2023. The regions covered in the lipid nanoparticles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lipid nanoparticles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lipid nanoparticles market consists of sales of solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid-based nanoparticles (LBNPs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Nanoparticles Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lipid nanoparticles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid nanoparticles? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lipid nanoparticles market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Nano-Structured Lipid Carriers (NLCs); Solid Lipid Nanoparticles (SLNs); Other Types
• 2) By Application: Research; Therapeutics
• 3) By End User: Pharmaceutical And Biotechnology Companies; Academics And Research Centers; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lipid Nanoparticles Market Characteristics

3. Lipid Nanoparticles Market Trends And Strategies

4. Lipid Nanoparticles Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Lipid Nanoparticles Market Size and Growth

• 5.1. Global Lipid Nanoparticles Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Lipid Nanoparticles Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Lipid Nanoparticles Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lipid Nanoparticles Market Segmentation

• 6.1. Global Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Nano-Structured Lipid Carriers (NLCs)
• Solid Lipid Nanoparticles (SLNs)
• Other Types
• 6.2. Global Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Research
• Therapeutics
• 6.3. Global Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academics And Research Centers
• Other End Users

7. Lipid Nanoparticles Market Regional And Country Analysis

• 7.1. Global Lipid Nanoparticles Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Lipid Nanoparticles Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lipid Nanoparticles Market

• 8.1. Asia-Pacific Lipid Nanoparticles Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lipid Nanoparticles Market

• 9.1. China Lipid Nanoparticles Market Overview
• 9.2. China Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lipid Nanoparticles Market

• 10.1. India Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lipid Nanoparticles Market

• 11.1. Japan Lipid Nanoparticles Market Overview
• 11.2. Japan Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lipid Nanoparticles Market

• 12.1. Australia Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lipid Nanoparticles Market

• 13.1. Indonesia Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lipid Nanoparticles Market

• 14.1. South Korea Lipid Nanoparticles Market Overview
• 14.2. South Korea Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lipid Nanoparticles Market

• 15.1. Western Europe Lipid Nanoparticles Market Overview
• 15.2. Western Europe Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lipid Nanoparticles Market

• 16.1. UK Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lipid Nanoparticles Market

• 17.1. Germany Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lipid Nanoparticles Market

• 18.1. France Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lipid Nanoparticles Market

• 19.1. Italy Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lipid Nanoparticles Market

• 20.1. Spain Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lipid Nanoparticles Market

• 21.1. Eastern Europe Lipid Nanoparticles Market Overview
• 21.2. Eastern Europe Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lipid Nanoparticles Market

• 22.1. Russia Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lipid Nanoparticles Market

• 23.1. North America Lipid Nanoparticles Market Overview
• 23.2. North America Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lipid Nanoparticles Market

• 24.1. USA Lipid Nanoparticles Market Overview
• 24.2. USA Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lipid Nanoparticles Market

• 25.1. Canada Lipid Nanoparticles Market Overview
• 25.2. Canada Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lipid Nanoparticles Market

• 26.1. South America Lipid Nanoparticles Market Overview
• 26.2. South America Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lipid Nanoparticles Market

• 27.1. Brazil Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lipid Nanoparticles Market

• 28.1. Middle East Lipid Nanoparticles Market Overview
• 28.2. Middle East Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lipid Nanoparticles Market

• 29.1. Africa Lipid Nanoparticles Market Overview
• 29.2. Africa Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lipid Nanoparticles Market Competitive Landscape And Company Profiles

• 30.1. Lipid Nanoparticles Market Competitive Landscape
• 30.2. Lipid Nanoparticles Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Abbott Laboratories
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Lipid Nanoparticles Market Other Major And Innovative Companies

• 31.1. Amgen Inc
• 31.2. The Merck Group
• 31.3. Evonik Industries AG
• 31.4. BioNTech SE
• 31.5. Moderna Inc.
• 31.6. Sanofi SA
• 31.7. Solid Biosciences Inc.
• 31.8. AstraZeneca PLC
• 31.9. NOF Corporation
• 31.10. Alnylam Pharmaceuticals Inc.
• 31.11. Nanomerics Ltd.
• 31.12. CordenPharma International
• 31.13. Nippon Fine Chemical
• 31.14. Helix Biotech Inc.
• 31.15. Dicerna Pharmaceuticals

32. Global Lipid Nanoparticles Market Competitive Benchmarking

33. Global Lipid Nanoparticles Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lipid Nanoparticles Market

35. Lipid Nanoparticles Market Future Outlook and Potential Analysis

• 35.1 Lipid Nanoparticles Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Lipid Nanoparticles Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Lipid Nanoparticles Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer